RTTNews | Mar 10, 2021 06:37AM EST

06:37 Wednesday, March 10, 2021 (RTTNews) - Affimed To Continue Enrollment In REDIRECT Trial For Patients With Relapsed Or Refractory CD30-positive PTCL

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved